← Leaderboards
Graeme Ayton Meintjes
University Of Cape Town
$3,614,424
Attributed
$4,438,406
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $656.2K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,438,406 · 3
By mechanism
D43$2,729,961 · 1
R01$1,647,965 · 1
D71$60,480 · 1
Top collaborators
- Elizabeth Phillips5 shared
Most similar at University Of Cape Town
Same institution · by research overlap
- Elizabeth Phillips$23,551,808
- Gary Maartens$1,581,257
- Karen Cohen$453,198
Others in their field
Top investigators on “Area”
- David Heimbrook · Leidos Biomedical Research, Inc.$781,609,239
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
AreaUniversitiesMemberTuberculosisTuberculosis DrugsCo-InfectionHiv/TbCollaborationsSymposiumFellowshipResearch PersonnelReportingTrainingGrantEpidemiologyInstitutionProgramsNext GenerationPathogenesisLiftingDrug KineticsDoctor Of PhilosophyCareerTraining Programs
Grant awards (16)
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)$308,214
R01 · FY2025 · AI · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$297,305
D43 · FY2025 · TW · contact PI
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)$319,378
R01 · FY2024 · AI · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$297,726
D43 · FY2024 · TW · contact PI
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)$330,076
R01 · FY2023 · AI · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$294,153
D43 · FY2023 · TW · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$296,981
D43 · FY2022 · TW · contact PI
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)$340,382
R01 · FY2021 · AI · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$308,041
D43 · FY2021 · TW · contact PI
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)$349,915
R01 · FY2020 · AI · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$306,261
D43 · FY2020 · TW · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$307,666
D43 · FY2019 · TW · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$311,783
D43 · FY2018 · TW · contact PI
HIV-associated Tuberculosis Training Program (HATTP)$310,045
D43 · FY2017 · TW · contact PI
HIV associated tuberculosis training program$30,240
D71 · FY2015 · TW · contact PI
HIV associated tuberculosis training program$30,240
D71 · FY2014 · TW · contact PI